Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today presented early data for its self-expanding Intrepid™ Transcatheter Mitral Valve Replacement (TMVR) System in patients with severe, symptomatic mitral regurgitation (MR) via the transfemoral access route. Transcatheter Cardiovascular ...